Health & Medicine
FDA Approves Controversial Cholesterol-Fighting Drug Despite Criticism From Cardiologists
The FDA approved the cholesterol-fighting drug Liptruzet Friday, despite criticism from cardiologists that studies have not shown the drug to be effective in lowering patients' chances of developing heart disease.
Latest Research Articles
Oral Drops Just as Effective as Shots for Asthma, Allergies
Parents Sucking on the Pacifier might Lower Allergies, Asthma Risk in Children
Researchers Treat Epilepsy in Mice
43 Percent Teens Text While Driving: Study
Vitamin C may Lower Lung Damage in Babies Caused by Maternal Smoking
Video Games Delay Cognitive Decline in Older Adults
Say Bye-Bye to Gray Hair, Researchers Find Way to Reverse The Process
Toxic Lipstick? Alarming Levels of Lead, Aluminum and Other Metals Found in Everyday Brands
Added Sugars Account For 13% Of Adults' Caloric Instake
Exercise May Help Reduce Risk Of Kidney Stones In Women
Chinese Lab Has 'No Common Sense' For Creating 'Dangerous' Viruses, Health Experts Say
ER Visits Following Adverse Reaction to Zolpidem Rise by 220 Percent




